Oncological patients remain in the high-risk group for COVID-19, doctors say
The article emphasizes that the treatment strategy for such patients should be based on the results of a detailed examination and include a phased, yet prompt approach in accordance with modern clinical protocols.
The authors of the study described two clinical cases of patients with a single lung who underwent radical surgery for lung cancer and were in long-term remission. Both patients underwent extended pneumonectomy in 2014 and were hospitalized in severe condition with a laboratory-confirmed diagnosis of COVID-19 in 2024.
Despite the challenging clinical circumstances and severe condition, both patients were able to successfully undergo treatment. Medical professionals believe that this was facilitated by rapid and active intervention carried out in strict accordance with the latest clinical recommendations.
Experts emphasize that although the COVID-19 pandemic is officially over, the risk of coronavirus infection continues to exist, especially for high-risk patients. Patients with a single lung fall into the category of extremely high risk, making them particularly vulnerable.
Doctors strongly recommend mandatory COVID-19 testing at the first signs of viral lung damage in such patients, as this can significantly reduce the risk of severe complications and negative outcomes.